Phase I Study of Mitoxantrone Hydrochloride Liposome Injection

NCT02131688 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Lymphoma

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.